recombinant mouse stem cell factor (rmscf) (Gemini Bio)
90
Structured Review
Gemini Bio
recombinant mouse stem cell factor (rmscf)
Recombinant Mouse Stem Cell Factor (Rmscf), supplied by Gemini Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+stem+cell+factor+(rmscf)/mouse+stem+cell+factor++mscf+/pm30209246-209-24-32
Average 90 stars, based on 1 article reviews
Recombinant Mouse Stem Cell Factor (Rmscf), supplied by Gemini Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/recombinant+mouse+stem+cell+factor+(rmscf)/mouse+stem+cell+factor++mscf+/pm30209246-209-24-32
Average 90 stars, based on 1 article reviews
recombinant mouse stem cell factor (rmscf) - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Modification:Article Title: Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopag. Article Snippet: Eltrombopag (EP), a small-molecule thrombopoietin receptor (TPO-R) agonist and potent intracellular iron chelator, has shown remarkable efficacy in stimulating sustained multilineage hematopoiesis in patients with bone marrow failure syndromes, suggesting an effect at the most immature hematopoietic stem and multipotent progenitor level.. Although the functional and molecular effects of EP on megakaryopoiesis have been studied in the past, mechanistic insights into its effects on the earliest stages of hematopoiesis have been limited.. We investigated the effects of EP treatment on hematopoietic stem cell (HSC) function using purified primary HSCs in separation-offunction mouse models, including a TPO-R–deficient strain, and stem cells isolated from patients undergoing TPO-R agonist treatment. Recombinant:Article Title: Thrombopoietin receptor-independent stimulation of hematopoietic stem cells by eltrombopag. Article Snippet: Eltrombopag (EP), a small-molecule thrombopoietin receptor (TPO-R) agonist and potent intracellular iron chelator, has shown remarkable efficacy in stimulating sustained multilineage hematopoiesis in patients with bone marrow failure syndromes, suggesting an effect at the most immature hematopoietic stem and multipotent progenitor level.. Although the functional and molecular effects of EP on megakaryopoiesis have been studied in the past, mechanistic insights into its effects on the earliest stages of hematopoiesis have been limited.. We investigated the effects of EP treatment on hematopoietic stem cell (HSC) function using purified primary HSCs in separation-offunction mouse models, including a TPO-R–deficient strain, and stem cells isolated from patients undergoing TPO-R agonist treatment. |